PharmaSource: The External Manufacturing Community Your Biopharma Outsourcing Intelligence Hub Trusted by 50,000+ biopharma manufacturing professionals Sign up for Newsletter LATEST NEWS Cytovance Biologics Launches Cell Line Development Services for Mammalian Programs Cytovance Biologics Launches Cell Line Development Services for Mammalian Programs Scinai Immunotherapeutics Reports Q1 2026 Results Following Recipharm Israel Deal FibroFind Appoints Co-Founder Lee Borthwick as CEO as Preclinical CRO Doubles in Size and Expands Leadership Team Resilience, Risk & Relationships – ExM Leaders Report Symeres Expands Spray Drying Capabilities at New Jersey CMC Site Axplora Consolidates UDCA Manufacturing at Vizag Site by End of 2026 Chime Biologics Expands Manufacturing Capacity With New GMP-2 Facility Chime Biologics Partners With Daewoong Pharmaceutical on Dupilumab Biosimilar Matica Biotechnology Partners With UHN on IL-10 Adenoviral Gene Therapy Manufacturing VIVEbiotech Expands In Vivo Gene Therapy Portfolio to 15 Programs Gaelic Laboratories Completes Phase 1 Integration With Athlone Laboratories Scinai Immunotherapeutics Reports Q1 2026 Results Following Recipharm Israel Deal FibroFind Appoints Co-Founder Lee Borthwick as CEO as Preclinical CRO Doubles in Size and Expands Leadership Team Resilience, Risk & Relationships – ExM Leaders Report PODCASTS Closing the Valley of Death: The Infrastructure Gap Holding Back Early-Stage Biologics Programs How Sanofi Navigates Regulatory CMC Across Global Markets: Insights from Manda Pasarkar SPOTLIGHT Why Compliance-Driven CDMOs Win Sponsor Contracts RESOURCES Resilience, Risk & Relationships – ExM Leaders Report [DOWNLOAD] Partnerships for an Uncertain World: The CDMO Live Europe 2026 Report Resilience, Risk & Relationships – ExM Leaders Report UPCOMING EVENTS External Manufacturing Leaders Basel 2026 CDMO Live Europe 2027 CDMO Live Americas 2026
FibroFind Appoints Co-Founder Lee Borthwick as CEO as Preclinical CRO Doubles in Size and Expands Leadership Team
FibroFind Appoints Co-Founder Lee Borthwick as CEO as Preclinical CRO Doubles in Size and Expands Leadership Team